NDAOPHTHALMICSOLUTION/DROPSPriority Review
Approved
Dec 2017
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
Priority Review
ALTAFLUOR BENOX (fluorescein sodium and benoxinate hydrochloride) by Engine Biosciences is 12. First approved in 2017.
Drug data last refreshed 11h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ALTAFLUOR BENOX is a fixed-dose combination ophthalmic solution containing fluorescein sodium (disclosing agent) and benoxinate hydrochloride (rapid-acting ester anesthetic). It provides corneal anesthesia within 5-45 seconds with a duration of approximately 20 minutes, suitable for diagnostic and minor ophthalmic procedures. The product combines visualization and pain relief in a single drop formulation.
Peak
Product is at peak lifecycle stage with moderate competitive pressure (30), suggesting stable commercial operations and established team structure.
Mechanism of Action
12. CLINICAL PHARMACOLOGY This product is the combination of a disclosing agent with a rapidly acting ester anesthetic of short duration. 12. 2 Pharmacodynamics Maximal corneal anesthesia usually occurs in about 5-45 seconds and lasts about 20 minutes after single administration. The anesthetic…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ALTAFLUOR BENOX represents a niche ophthalmic specialty product with zero current linked job openings, suggesting a small, stable brand team focused on maintenance and relationship management rather than growth. Career opportunities on this product would emphasize deep ophthalmology market knowledge, prescriber relationship building, and execution excellence in a focused specialty segment.
Brand Manager
Worked on ALTAFLUOR BENOX at Engine Biosciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.